Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
But just hours after employees were shown the door, Barclay Butler, the agency’s new chief operating officer, asked top FDA ...
1don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
But the FDA under the new Trump administration is already starting to look dramatically different. It’s hard to keep track of how many people have left, with departures stemming from early retirements ...
The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The job cuts have impacted researchers, scientists, and senior officials, leading to the loss of key figures who shaped U.S. policies on drug approvals, medical research, and public health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results